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The medial prefrontal cortex (mPFC) plays a key role in behavioral variability, action
monitoring, and inhibitory control. The functional role of mPFC may change over
the lifespan due to a number of aging-related issues, including dendritic regression,
increased cAMP signaling, and reductions in the efficacy of neuromodulators to influence
mPFC processing. A key neurotransmitter in mPFC is norepinephrine. Previous studies
have reported aging-related changes in the sensitivity of mPFC-dependent tasks to
noradrenergic agonist drugs, such as guanfacine. Here, we assessed the effects of
yohimbine, an alpha-2 noradrenergic antagonist, in cohorts of younger and older rats in
a classic test of spatial working memory (using a T-maze). Older rats (23–29mo.) were
impaired by a lower dose of yohimbine compared to younger animals (5–10mo.). To
determine if the drug acts on alpha-2 noradrenergic receptors in mPFC and if its effects
are specific to memory-guided performance, we made infusions of yohimbine into mPFC
of a cohort of young rats (6mo.) using an operant delayed response task. The task
involved testing rats in blocks of trials with memory- and stimulus-guided performance.
Yohimbine selectively impaired memory-guided performance and was associated with
error perseveration. Infusions of muscimol (a GABA-A agonist) at the same sites also
selectively impaired memory-guided performance, but did not lead to error perseveration.
Based on these results, we propose several potential interpretations for the role for the
noradrenergic system in the performanceof delayed response tasks, including the encoding
of previous response locations, task rules (i.e., using a win-stay strategy instead of a
win-shift strategy), and performance monitoring (e.g., prospective encoding of outcomes).
Keywords: aging, behavioral flexibility, cognitive control, muscimol, noradrenaline, prefrontal cortex, working
memory, yohimbine
INTRODUCTION
Medial parts of the prefrontal cortex (mPFC) have been impli-
cated in the executive control of behavior. Lesions of mPFC
result in disrupted instrumental learning (Corbit and Balleine,
2003), impairments in the inhibitory control of action (Passetti
et al., 2002; Risterucci et al., 2003; Narayanan and Laubach,
2006), diminished flexibility following changes in the rules that
govern action selection (Dias and Aggleton, 2000; Young and
Shapiro, 2009), and deficits in performance adjustments after
errors (Narayanan and Laubach, 2008). mPFC neurons become
active when inappropriate or premature responses must be with-
held (Narayanan and Laubach, 2006; Totah et al., 2009), when
mistakes aremade on prior trials (Narayanan and Laubach, 2008),
and when action-reward contingencies are changed (Kargo et al.,
2007; Rich and Shapiro, 2009). Based on these studies, mPFC
seems crucial for two executive functions, inhibitory control, and
behavioral flexibility.
Although the dopamine, serotonin, and noradrenaline (NA)
systems have been implicated in executive functions [see Robbins
and Roberts (2007) for review], the noradrenergic system in
particular has been implicated in working memory (Arnsten
and Goldman-Rakic, 1985; Wang et al., 2007), inhibitory control
(e.g., Ma et al., 2003), and behavioral flexibility (e.g., Lapiz and
Morilak, 2006). Studies using attentional set-shifting paradigms
have shown that when the concentration of NA is reduced in PFC
by lesioning the dorsal noradrenergic ascending bundle (DNAB)
(Tait et al., 2007) or by manipulating alpha-2 NA autoreceptors
(Lapiz andMorilak, 2006), the ability of rats to shift attention to a
newly reward-relevant dimension in the environment is reduced.
Theoretical studies have implicated the NA system within the
mPFC in behavioral flexibility (Aston-Jones and Cohen, 2005;
Bouret and Sara, 2005; Dayan and Yu, 2006). Recordings in the
locus coeruleus during a signal-detection task found that NA
neurons fire in a phasic manner when monkeys perform the
task correctly and fire in a tonic manner when animals make
mistakes (e.g., Clayton et al., 2004). Increased tonic activity by
NA neurons leads to release of NA in the mPFC via the DNAB
(Devauges and Sara, 1990). As such, blocking the ability of the
NA system to regulate mPFC processing, e.g., using the selective
alpha-2 antagonist yohimbine, should lead to error perseveration
and a consequent impairments in behavioral flexibility. This
hypothesis was tested in the present study using intra-cerebral
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infusions of yohimbine and muscimol during an operant delayed
response task. The task was based on Horst and Laubach (2009,
2012), and was designed to assess memory and stimulus-guided
responding in separate blocks of trials. Our findings suggest a
role for the NA system within the mPFC in the control of error
perseveration during memory-guided, but not stimulus-guided,
performance.
The NA system may be especially important for cognitive con-
trol in aging. In both rats and monkeys, neurons in the frontal
cortex exhibit significant anatomical alterations over the lifespan,
such as dendritic regression (Grill and Riddle, 2002; Markham
and Juraska, 2002; Duan et al., 2003; Dumitriu et al., 2010). These
changes in neuronal complexity are accompanied by changes
in NA in the mPFC, including reductions in projections from
the locus coeruleus starting at 15 months (Ishida et al., 2000),
decreases in NA synapses (Ishida et al., 2001a), and decreases in
NA uptake, possibly due to the NA transporter and not to presy-
naptic autoreceptors (Shirokawa et al., 2003). Importantly, these
changes are observed despite there being normal levels of NA in
PFC in aged rats (Ishida et al., 2001b) and no major loss of cells in
locus coeruleus in both aged human beings (Mouton et al., 1994)
and rats (Goldman and Coleman, 1981). However, there are age-
related decreases in alpha-2 receptors in the primate PFC, which
may reflect reduced pre-synaptic receptors on NA synapses, but
may also arise from reduced post-synaptic alpha-2 receptors on
the spines of PFC pyramidal cells essential for working memory.
The persistent firing of PFC networks is needed for both work-
ing memory and behavioral inhibition (Funahashi et al., 1993).
Post-synaptic alpha-2A receptors have an essential influence on
PFC working memory circuits in rodents and primates, inhibit-
ing cAMP-PKA opening of HCN (Hyperpolarization-activated
Cyclic Nucleotide gated), and KCNQ channels to strengthen PFC
network firing (Wang et al., 2007, 2011). In monkey PFC, alpha-
2A receptors, HCN channels, and KCNQ channels have all been
located on the post-synaptic membranes of pyramidal cell spines,
next to glutamate, NMDA synapses (Aoki et al., 1998; Wang et al.,
2007; Arnsten et al., 2012; Paspalas et al., 2012). Systemic or local
stimulation of alpha-2A receptors with clonidine or guanfacine
increases task-related firing during a working memory task, while
blockade of these receptors with yohimbine markedly reduces
PFC network firing (Li et al., 1999; Wang et al., 2007). Similar
effects are seen on performance of a working memory task, where
systemic or local administration of alpha-2 agonists improves
working memory in rodents and primates, particularly in aged
animals (Arnsten and Goldman-Rakic, 1985; Arnsten et al., 1988;
Rama et al., 1996; Tanila et al., 1996). Conversely, systemic or local
blockade of alpha-2 receptors with yohimbine impairs working
memory performance (Arnsten andGoldman-Rakic, 1985; Li and
Mei, 1994), as well as impulse control (Ma et al., 2003). Thus, loss
of this key regulation with advancing agemay contribute substan-
tially to age-related cognitive decline. In aged monkey PFC, the
reduction in persistent firing during working memory can be res-
cued by guanfacine (Wang et al., 2011). However, these data also
suggest that the aged brain should also show altered sensitivity
to NA receptor antagonists. To address this issue, we examined if
there are age-related differences in the sensitivity of the mPFC to
the alpha-2 antagonist yohimbine, using a standard T-maze task.
Together, our studies provide the first direct evidence for the
noradrenergic system within themPFC in the control ofmemory-
guided performance and for aged animals being more sensitive to
manipulations of noradrenergic processing.
MATERIALS AND METHODS
All experimental procedures were approved by the Animal Care
and Use Committee at Yale University (Study 1) and The John B.
Pierce Laboratory (Study 2), and conform to guidelines for the
Ethical Treatment of Animals (National Institutes of Health).
STUDY 1, T-MAZE DELAYED ALTERNATION TASK
Subjects
Nine aged (23–29-months old; Harlan) and seven young adult
(5–10-months old; Taconic) male Sprague-Dawley rats were
included in Study 1. They were extensively handled before train-
ing commenced. Throughout the behavioral training, all rats
had unlimited access to water and regulated food access (16 g of
standard chow per day).
Behavioral apparatus
Aged and young rats were trained in a delayed alternation task in
a T-shaped maze (90 × 65 cm). The maze was composed of the
start box at the bottom of the “T,” the center arm, and the right
and left arms at the top of the “T” (Figure 1A). When the gate of
starting box was lifted, the rat could move forward in the center
arm and choose to enter the left or right arm to collect highly
palatable miniature chocolate chips.
Training protocol
Rats were trained in a delayed alternation task based on methods
described in Ramos et al. (2003). First, they were habituated to
the T-maze until they were readily eating chocolate chips placed
at the end of each arm. Then, training on the delayed alterna-
tion task commenced. In the first trial, animals were rewarded
(i.e., collected the chocolate chips) for entering either arm, after
which they were picked up and put back into the start box for a
delay period. In the next 10 trials, rats were rewarded only if they
entered the arm that was not chosen in the previous trial. During
the delay period, the T-maze was wiped with alcohol to remove
any olfactory clues left from the previous trial. Rats were tested
for 1 session (11 trials) daily. The delay periods were adjusted
for each rat to maintain performance at a stable baseline level
(60–80% correct), ranging from 5 to 25 s. If they performed at
90–100% correct for two consecutive days, their delay periods
were raised by 5 s.
Drug injections
When performance of rats trained in the T-maze was at base-
line level for two consecutive days, they received an intraperi-
toneal mock injection (needle poke with no fluids injected) right
before the daily session. If performance was at baseline level
after the mock injection, then injections with yohimbine were
administered in the following day.
Yohimbine hydrochloride (Tocris) was dissolved in sterile
water at various concentrations. The drug was delivered system-
ically via intraperitoneal injections 20min before testing. There
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FIGURE 1 | (A) The T-maze used in Study 1. (B) Percent correct for aged
(black bars) and young rats (gray bars) after vehicle and yohimbine injections.
Paired-samples t-test, Veh vs. Yoh, t(8) = 5.93, p < 0.001 for aged rats; and
t(6) = 8.65, p < 0.001 for young rats. (C) Lowest dose of yohimbine to impair
performance. One-Way ANOVA, F(1, 14) = 29.88, p < 0.001. Error bars are
SEM. ∗∗Denotes p < 0.01.
was at least a week between each drug administration test session.
Rats were first injected with vehicle (sterile water). If perfor-
mance was still at baseline, then various doses of yohimbine
(0.1–6mg/kg) were tested as follows: each rat received a randomly
chosen dose between 1 and 6mg/kg. If the chosen dose caused
impairment, the dose was lowered by 0.2–1mg/kg until there
was no impairment observed. As a result of this procedure, the
number of doses differed over rats.
STUDY 2, DELAYED RESPONSE TASKS
Subjects
Six young adult (6 months old at the start of training)
male Brown Norway rats (Harlan) were maintained at ∼85%
of their free-feeding body weight with unlimited access to
water and regulated food access throughout the behavioral
training.
Behavioral apparatus
Rats were trained in two delayed response tasks, based on
methods described in Caetano et al. (2012). Standard operant
boxes (ENV-008, Med Associates) equipped with a custom-
made lever (The John B. Pierce Laboratory Instruments Shop),
two diffuse houselights (ENV-215M, Med Associates), two
head entry apertures (referred to as “reward ports”), and two
LEDs located inside the reward ports (Figure 2) were used.
The reward ports had spouts that delivered liquid sucrose
and were equipped with infrared beams (ENV-114BM, Med
Associates), which recorded times of head entries and licks to the
spouts.
Surgeries
Before training, all rats in Study 2 were implanted bilaterally
with 26-gauge 4mm-long cannulae (Plastics One) into mPFC
as described in Narayanan et al. (2006). Cannulae were targeted
in mPFC at the following coordinates: AP: +3.2, ML: ±1.4,
DV: −2.8 at 12◦ from the midline (See Figure 2E for locations of
cannula tips).
Training protocols
Memory-guided task. Rats were trained to perform an operant
delayed alternation task as described in Caetano et al. (2012) over
20–25 sessions until they performedwith an accuracy greater than
75% correct. Then, the rats were trained to perform a simple
reaction-time task (using methods from Narayanan et al., 2006)
and were shifted back to the delayed alternation task and expe-
rienced blocks of trials under memory and stimulus-guidance
over 10–15 sessions. At this point, the rats were implanted with
infusion cannulas and tested as described below.
A successful trial in the memory-guided task went as follows
(Figure 2B): after a head entry into the left reward port, the
light above the lever turned on and the rat moved to the lever
(Figure 2B, arrow 1). The first lever press delivered ∼0.05ml of
20% sucrose solution at the spout above the lever, turned off the
light above the lever, and turned on the light above the reward
ports (Go stimulus). After choosing the correct (alternate) reward
port (Figure 2B, arrow 2), the light above the reward ports turned
off, the light above the lever turned on, and ∼0.05ml of 20%
sucrose solution was delivered from the spout inside the correct
port. If the rat chose the same port from the previous trial (incor-
rect trial), no liquid sucrose was delivered and the trial restarted.
After incorrect trials, the same reward port assignment was kept
for the next trial (correction trial). Rats were trained in 60-min
daily sessions (excluding weekends).
Stimulus-guided task. The stimulus-guided task was similar
to the memory-guided procedure, except that the Go stimulus
was presented inside the left or right reward port (determined
randomly across trials and with no correction trials), and its
location defined the assigned correct port for a head entry in
each trial (Figure 2C). Therefore, the rats had to break from the
“alternationmode” and “track the stimulus” to receive the reward.
When performance was >75% correct in the stimulus-guided
task, all rats were exposed to the two tasks within the same
training session. Each session started with a block of memory
or stimulus-guided trials (counterbalanced across rats), and
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FIGURE 2 | (A) Experimental box at the time of the Go stimulus
and (B) performance of a correct trial in the memory-guided task.
(C) A rat in the stimulus-guided task, in which a light inside one of
the reward ports indicated the location for a correct head entry after a
lever press. (D) Spread of 2µL injections of the dye Pontamine sky
blue into the mPFC of an untrained rat, shown over a series of
∼50µm thick sections. The center of the infusion in the left
hemisphere is shown in the left brain section. The center of the
infusion in the right hemisphere is shown in the right brain section.
The center image was located between the two infusion sites. Note
that the dye was retained within the medial prefrontal cortex.
(E) Locations of infusion sites based on reconstructions of tissue
dispersion patterns (shown as gray shaded areas) at the end of the
tracks made by the guide cannula. In each rat, the cannula ended
within the medial prefrontal cortex (Cg1/PrL areas). (Images are based
on Paxinos and Watson, 1998).
switched every time the rats completed 40 correct trials. After
two 60-min sessions on this mixed protocol, the testing sessions
commenced. Rats experienced 10–15 sessions of training in the
stimulus-guided task and sessions with shifting versions of the
two tasks.
Drug infusions
The goal of this study was to assess the effects of blocking alpha-2
NA receptors, using yohimbine, in the mPFC during the operant
delayed response task. The dose, volume, and timing for testing
were based on the study by Ma et al. (2003). After we found
effects of yohimbine on the animals’ performance of the task,
we tested the animals with infusions of muscimol (to carry out
reversible inactivation) to determine if cortical sites that were
sensitive to alpha-2 blockade were also sensitive to reversible
inactivation. For this reason, we did not counterbalance the
order of drug testing and did not test a wide range of doses of
yohimbine.
Over three consecutive days, each rat received a bilateral infu-
sion of saline (day 1), yohimbine (day 2), and a recovery session
with no infusions (day 3). Rats were run on the mixed protocol
with the same order of counterbalancing of initial tasks across all
sessions. At the end of the experiment all rats received bilateral
infusions of muscimol and a second recovery session.
Infusions were done as described in Narayanan et al. (2006).
Rats were briefly anesthetized with 4% isoflurane to ensure a low
level of stress and a high level of consistency across infusions
(testing done in sessions prior to infusions showed no effects of
brief anesthesia in these tasks). A total volume of 2µl of sterile
saline (0.9%; Phoenix Scientific) and yohimbine hydrochloride
(5µg/µL) (Tocris) dissolved in saline were delivered bilaterally at
a rate of 0.5µL/min. The spread of a 2µl infusion into mPFC
was assessed in an untrained rat with 1% pontamine sky blue
(following the protocol by Li and Mei, 1994), and was suffi-
cient to cover most of—but was confined to—the target region
(mPFC) (Figure 2D). At the end of the experiment, 0.5µl of
muscimol (0.05µg/µL) (Tocris) dissolved in saline was delivered
bilaterally at a rate of 0.25µl/min. Previous studies have used
this volume and rate of fluorescent muscimol infusions to con-
firm the approximate extent of cortical inactivation in mPFC,
which is estimated at approximately 1mm2 (Narayanan et al.,
2006; Allen et al., 2008). Rats were tested 15min after infu-
sion of saline and yohimbine (Li and Mei, 1994), and 45min
after infusion of muscimol to allow maximal inhibition of cor-
tical activity (Martin and Ghez, 1999; Allen et al., 2008). Please
note that given differences in the volumes infused for yohim-
bine and muscimol and the estimates of spread made using
dye (Figure 2D), the effects of muscimol were likely to occur
over a smaller total cortical volume that than obtained with
yohimbine.
Histology
Once experiments were complete, rats in Study 2 were anes-
thetized with 1ml Euthasol and transcardially perfused with 10%
formalin. Brains were later sectioned, mounted, and stained for
Nissl with thionin using standard methods.
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Cannula tracts were based on microscopic assessment of
thionin-stained sections, made using a Motic microscope and a
BioQuant computer-assisted reconstruction system. Drug injec-
tion sites were estimated based on cannula tracts and regions with
tissue dispersion at the tips of the cannula tracts. Sections with
evidence for cannula tracts and tissue dispersion at the tips of
the tracts were mapped onto standard atlas sections (Paxinos and
Watson, 1998).
Two of six implanted rats were excluded from the study. One
rat did not have both guide cannulas in the mPFC. One cannula
was implanted into the most rostral medial frontal cortex and
the other appeared to have destroyed the medial frontal cortex
along the edge of the hemisphere. Infusions on this side likely
went directly into the brain case. Another rat appeared to have
blocked cannulas and it was not possible to infuse any drugs in
this animal.
Data analysis
The number of trials completed in the 60min testing sessions
differed across the three testing sessions (One-Way ANOVA,
F(2, 6) = 5.26, p < 0.05). Mean number of trials (and SEM) were
169.3 (±36) for saline, 222.5 (±21.6) for yohimbine, and 221
(±20.5) for recovery sessions. Therefore, to standardize the num-
ber of trials analyzed across subjects and conditions, only the
first two blocks of trials per session were used (i.e., two rats
with a block of memory-guided trials followed by a block of
stimulus-guided trials, and two rats with stimulus- followed by
memory-guided trials). Performance in the muscimol session
was compared with performance in the immediately following
recovery session.
RESULTS
STUDY 1—AGE-RELATED IMPAIRMENT OF YOHIMBINE ON SPATIAL
WORKING MEMORY PERFORMANCE
Systemic injections of yohimbine significantly impaired perfor-
mance in the T-maze for both young and aged rats. After yohim-
bine injections, percent correct trials decreased for both groups of
rats compared to performance after vehicle injections [Figure 1B;
paired-samples t-test, Veh vs. Yoh, t(8) = 5.93, p < 0.001 for aged
rats; and t(6) = 8.65, p < 0.001 for young rats]. Performance
in young rats under yohimbine was below chance (50% cor-
rect; Figure 1B), a finding that suggests yohimbine may cause a
transition from rule-guided alternations to perseverative actions.
This hypothesis was tested in the second part in this study.
Interestingly, aged rats were more sensitive to the effects of
yohimbine than younger rats. The lowest doses that impaired per-
formance were significantly lower in aged rats compared to young
rats [Figure 1C; One-Way ANOVA, F(1, 14) = 29.88, p = 0.001].
To assess if the higher effective dose in young rats was due to the
more severe impairment found in the younger animals, we com-
pared the slightly lower doses which did not cause impairments
in young rats with the impairment-producing doses in aged
rats, and found the difference still significant [One-Way ANOVA,
F(1, 14) = 18.34, p < 0.001, data not shown]. These results sug-
gest that lower doses are required to impair performance in aged
animals.
STUDY 2—NORADRENERGIC EFFECTS ON PERFORMANCE ACCURACY
IN THE MEMORY- AND STIMULUS-GUIDED TASKS
Yohimbine infusions selectively decreased accuracy in the
memory-guided task (Figure 3A, black bars) compared to the
saline session, and rebounded to control levels in the recovery
session [One-Way ANOVA, F(2, 6) = 9.13, p = 0.015; paired-
samples t-test: Sal vs. Yoh, t(3) = 8.49, p = 0.003; Yoh vs. Rec,
t(3) = 3.38, p = 0.043]. Yohimbine infusions had no effect in
accuracy during stimulus-guided trials [gray bars; One-Way
ANOVA, F(2, 4) = 0.65, p = 0.569]. One rat (Rat 2) was excluded
from the analysis of percent correct in the stimulus-guided task
because after reaching 40 correct trials in the initial memory-
guided task after saline infusion, it completed only a few trials
in the stimulus-guided task. This rat, however, completed 172
and 169 overall trials in the yohimbine and recovery sessions,
respectively, with >75% correct accuracy in the stimulus-guided
trials.
Figure 3B shows the effects of yohimbine on the number of
trials required to reach the performance criterion in each block
FIGURE 3 | (A) Percent correct trials in the memory-guided (black bars) and
stimulus-guided (gray bars) tasks after saline (Sal), yohimbine (Yoh), and in a
recovery session (Rec). Error bars are SEM. ∗Denotes p < 0.05. (B) Trials to
reach the performance criterion in the memory-guided trials (left panel) and in
the stimulus-guided trials (right panel), and percent of rats that reached the
criterion (rightmost panel).
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of trials (left panels), defined as 90% correct performance over a
block of 10 consecutive trials, and the percent of rats that reached
this criterion (rightmost panel). After yohimbine infusions, one
rat required many more trials to reach that criterion in the
memory-guided block compared to the saline session (Rat 2, from
19 to 58 trials), while the remaining three rats did not reach the
criterion at all. In contrast, all rats reached the performance crite-
rion in the stimulus-guided task in all testing sessions (Figure 3B,
right plot; gray bars in rightmost panel). Note that yohimbine
consistently disrupted performance in the memory-guided trials
regardless of whether this block of trials was the first or second in
the session (counterbalanced across rats).
NORADRENERGIC EFFECTS ON ERROR PERSEVERATION
The distribution of errors after yohimbine infusions dif-
fered from the distribution of errors during saline infusions
(Friedman’s ANOVA, X2 = 4.3, p = 0.038) and during recovery
(Friedman’s ANOVA, X2 = 7.1, p = 0.008) in memory-guided
trials (Figure 4A). Specifically, the number of two or more con-
secutive errors increased in the yohimbine session (Figure 4B).
These results suggest that mPFC infusions of yohimbine impaired
the ability of rats to adjust performance after mistakes.
MUSCIMOL REDUCED ACCURACY IN THE MEMORY BLOCKS BUT DID
NOT LEAD TO PERSEVERATION
In order to confirm the involvement of the yohimbine-sensitive
sites in spatial working memory performance, mPFC was inacti-
vated with bilateral infusions of muscimol. Compared with the
following recovery session, muscimol infusions decreased per-
cent correct trials in the memory-guided task [Figure 5A, black
bars; Paired-samples t-test, t(3) = 11.37, p = 0.002], but not in
the stimulus-guided task [Figure 5A, gray bars; Paired-samples
t-test, t(3) = 0.72, p = 0.523]. In contrast to yohimbine infusions,
after muscimol infusions only one rat was unable to reach the per-
formance criterion in the memory-guided task (Rat 2) or in the
stimulus-guided task (Rat 4) (Figure 5B).
LACK OF EFFECTS OF YOHIMBINE AND MUSCIMOL INFUSIONS ON
TEMPORAL ASPECTS OF THE TASKS
Yohimbine and muscimol infusions did not alter the time spent
by the rats at the lever or at the reward ports, the time to tran-
sition between those components (move to/from the ports), or
the total trial time in either task (One-Way ANOVA: p >> 0.05
for all measures; Figure 6). When data from the two tasks were
collapsed, no consistent effect of either drug was found in any of
the temporal measures or in the proportion of trials in which the
rats checked both reward ports within the same trial. These null
results suggest that neither drug increased impulsivity in the tasks.
DISCUSSION
In Study 1, older rats were impaired on the T-maze by lower
doses of yohimbine compared to younger animals. In Study 2,
performance was impaired by infusions of yohimbine into mPFC
during the memory-guided, but not the stimulus-guided, task.
Rats infused with yohimbine made more consecutive errors when
performing based onmemory, suggesting that their ability to cor-
rect performance after mistakes was diminished. These results
implicate the NA system within mPFC inmemory-specific behav-
ioral adjustments. To our knowledge, the present study is the first
report of such memory-specific effects of the NA system within
the rodent mPFC.
Yohimbine has also been shown to impair behavioral
performance in a variety of species and paradigms. In Ma et al.
(2003), for example, monkeys subjected to prolonged infusion
of yohimbine into PFC were unable to withhold responding
in a go/no-go task. PFC infusions of yohimbine also impaired
performance in working memory tasks in monkeys, such as
FIGURE 4 | (A) Proportion of consecutive errors in the memory-guided
task. Note that the proportion of sequential errors increased under
yohimbine, leading to a lower overall proportion of isolated errrors.
(B) Boxplots with the number of two or more consecutive errors in the
testing sessions. Gray dots depict the values for each of the four rats.
Dashed lines link the median values for more than two consecutive
errors, which were significantly different by Friedman’s ANOVA at
p < 0.05.
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FIGURE 5 | (A) Percent correct trials in the memory-guided (black bars)
and stimulus-guided (gray bars) tasks after muscimol infusions (Mus), and
in a recovery session (Rec). Error bars are SEM. ∗∗Denotes p < 0.01.
(B) Trials to reach the performance criterion in the memory- and
stimulus-guided trails after muscimol infusions (Mus) and in the recovery
session (Rec).
FIGURE 6 | Non-specific effects of mPFC infusions of yohimbine.
Yohimbine and muscimol infusions did not alter the time spent in
each task component or the time to transition between components
(One-Way ANOVAs: p >> 0.05, for all measures). (A) Average (and
SEM) time spent to move from the lever to the reward ports in the
5 testing sessions. (B) Average (and SEM) time spent to move from
the reward ports to the lever in the 5 testing sessions. (C) Average
(and SEM) time spent at the reward ports in the 5 testing sessions.
(D) Average (and SEM) time spent completing one trial in the 5
testing sessions.
the delayed-response task (Li and Mei, 1994; Li et al., 1999)
and the oculomotor delay-response task (Sawaguchi, 1998). In
rats, intraperitoneal injections of yohimbine increased prema-
ture responding in a differential reinforcement of low response
rate (DRL) schedule (Sanger, 1988). Moreover, administration of
alpha-2 NA agonists, such as guanfacine or clonidine, has been
shown to enhance performance in spatial memory tasks (Li et al.,
1999; Wang et al., 2011).
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Despite these reports, opposing effects have been observed in
rats tested under alpha-2 NA antagonists in other paradigms,
supporting the view that manipulations of monoamines within
PFC may have task-specific effects (Arnsten, 1998). For example,
monoamine depletions in PFC impair spatial working mem-
ory performance (e.g., Collins et al., 1998) but not performance
on set-shifting tasks (e.g., Roberts et al., 1994). Studies that
manipulated the NA system, in particular, support the notion
of task-dependent effects. Increasing the concentration of NA
in mPFC via intraperitoneal injections of idazoxan (Devauges
and Sara, 1990), and mPFC infusions of atipamezole (Lapiz and
Morilak, 2006), both of which are alpha-2 NA antagonists, have
been shown to enhance cognitive performance in attentional set-
shifting tasks. When NA is depleted in mPFC through lesions
of the DNAB, cognitive performance in those tasks is impaired
(Tait et al., 2007). There are at least three plausible interpretations
of these findings. First, alpha-2 NA antagonists improve perfor-
mance in tasks that involve stimulus-outcome associations, such
as attentional set-shifting tasks, but impair performance in tasks
that rely on action-outcome associations, such as spatial tasks.
Second, alpha-2 NA antagonists affect aspects of temporal order
processing that are involved in delayed response alternation tasks
but not in stimulus-tracking tasks. Third, alpha-2 receptor stim-
ulation helps to maintain an attentional set through increased
persistent firing, and these physiological actions which strengthen
working memory also interfere with the ability to shift attentional
set. New studies are needed to resolve these issues.
In Study 2, percent correct in the stimulus-guided task was
unaffected by the yohimbine infusions, both at the beginning
of the session and after a block of memory-guided trials. The
stimulus-guided task involved the same set of movements and
actions used in the memory-guided task, but instead of relying on
internal cues (reward port visited in the previous trial) rats had to
rely on an external cue (location of the Go stimulus). In a related
stimulus-guided task, Sun et al. (2010) also reported no effects of
intraperitoneal injections of yohimbine in accuracy. Instead, the
authors observed an increase in impulsivity in the rats, indicated
by an increase in premature entries into the apertures. An increase
in premature responding has also been observed in response to
muscimol inactivation of mPFC in rats trained in a simple reac-
tion time task (e.g., Narayanan et al., 2006) and in response to
intraperitoneal injections of yohimbine in rats trained in a DRL
schedule (Sanger, 1988). These results are in agreement with the
idea that PFC exerts inhibitory control of actions with a possible
involvement of the noradrenergic system.
In the present study, reversible inactivations of mPFC with
muscimol led to impairment only in the memory-guided task,
which confirms the involvement of mPFC in spatial working
memory performance (Horst and Laubach, 2009) and strategy
switching (Rich and Shapiro, 2009). The effects of muscimol
reported in this study are less dramatic compared to another
study from our lab (Horst and Laubach, 2009). A key differ-
ence between these studies is that the interval between responses
in the present study was only a few seconds, much shorter
than the delays used in Horst and Laubach (2009). In the
present study, inactivation of mPFC did not alter the number
of trials required for rats to reach the performance criterion
(Figure 5B). Likewise, in our previous study we found no evi-
dence for error perseveration following inactivation of mPFC
during a standard operant delayed alternation task (Horst and
Laubach, 2009). Therefore, we propose that our present results
suggest that blocking a single modulatory input tomPFC (alpha-2
noradrenergic receptors) leads to a specific change in perfor-
mance that is distinct from inhibiting processing within the
cortical region.
The effects of the alpha-2 NA antagonist could be due to
changes in the excitability of mPFC networks (Ji et al., 2008;
Mueller et al., 2008), an effect that is opposite to muscimol (van
Duuren et al., 2007). However, both the Ji and Mueller stud-
ies did not assess mPFC activity in tasks that are known to
depend on mPFC processing, as in the types of delayed response
tasks that are used in the present study. A plausible hypoth-
esis for the actions of yohimbine in mPFC is that it disrupts
normal patterns of network activity that may occur in advance
of errors, as found in a recent human EEG study (Cavanagh
et al., 2009). If the same process exists in rats and is sensi-
tive to manipulations of the NA system, then our rats would
be unable to monitor behavioral outcomes and adjust perfor-
mance when mistakes are likely to be made. Neuronal evidence
for such prospective coding of behavioral outcomes has been
reported during an mPFC-dependent simple reaction-time task
(Narayanan and Laubach, 2006) and two types of spatially delayed
response tasks (Hyman et al., 2011, 2012; Horst and Laubach,
2012).
This mechanism of action would be different from a total
inactivation of mPFC and may explain how blocking a single
modulatory input to mPFC (alpha-2 noradrenergic receptors)
would lead to a specific change in performance that is dis-
tinct from effects of a more general inhibition by muscimol.
Along these lines, electrophysiological studies in rats (e.g., Bouret
and Sara, 2004) and non-human primates (Clayton et al., 2004;
Aston-Jones and Cohen, 2005) have suggested the involvement
of the NA system in behavioral flexibility, and computational
studies have proposed that the activity of noradrenergic neu-
rons within mPFC may serve as a network reset signal that
correlates with behavioral flexibility and arises when behavior
adjustment is needed (Bouret and Sara, 2005; Dayan and Yu,
2006). Several recent studies have reported evidence for the cross-
trial encoding of behavioral outcomes in the frontal cortex during
non-spatial (e.g., Seo and Lee, 2007; Narayanan and Laubach,
2008; Quilodran et al., 2008; Histed et al., 2009; Totah et al., 2009)
and spatial (Horst and Laubach, 2012; Hyman et al., 2012) tasks.
It is possible that neural activity associated with these cross-trial
encodings of behavioral outcome depends on the alpha-2 NA sys-
tem. Resolving this issue should be a future direction of research
on the mPFC.
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